Acadia Pharmaceuticals Stock Cycle Indicators Hilbert Transform Trend vs Cycle Mode

ACAD Stock  USD 16.54  0.17  1.04%   
ACADIA Pharmaceuticals cycle indicators tool provides the execution environment for running the Hilbert Transform Trend vs Cycle Mode indicator and other technical functions against ACADIA Pharmaceuticals. ACADIA Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Trend vs Cycle Mode indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of ACADIA Pharmaceuticals price series.

Indicator
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Trend vs Cycle Mode is Hilbert Transform indicator that generates in-phase and quadrature components of ACADIA Pharmaceuticals price series in order to analyze trend vs cycle patterns of ACADIA Pharmaceuticals.

ACADIA Pharmaceuticals Technical Analysis Modules

Most technical analysis of ACADIA Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ACADIA from various momentum indicators to cycle indicators. When you analyze ACADIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About ACADIA Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ACADIA Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of ACADIA Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing ACADIA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ACADIA Pharmaceuticals's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of ACADIA Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for ACADIA Pharmaceuticals, we also check how macroeconomic factors affect ACADIA Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover2.780.82.612.48
Days Of Inventory On Hand150.28238.26285.89153.81
Hype
Prediction
LowEstimatedHigh
14.3316.6018.87
Details
Intrinsic
Valuation
LowRealHigh
14.8920.1922.46
Details
20 Analysts
Consensus
LowTargetHigh
28.4431.2534.69
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.100.180.27
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ACADIA Pharmaceuticals. Your research has to be compared to or analyzed against ACADIA Pharmaceuticals' peers to derive any actionable benefits. When done correctly, ACADIA Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ACADIA Pharmaceuticals.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether ACADIA Pharmaceuticals is a strong investment it is important to analyze ACADIA Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ACADIA Pharmaceuticals' future performance. For an informed investment choice regarding ACADIA Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ACADIA Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
28.347
Earnings Share
0.78
Revenue Per Share
5.622
Quarterly Revenue Growth
0.183
Return On Assets
0.0872
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.